News

Pharmabiz2h
A N Mohan re-elected president, Antony Tharyan, general secretary as AKCDA tackles expiry settlement debate
Peethaambaran Kunnathoor, Chennai Tuesday, July 1, 2025, 08:00 Hrs [IST] ...
Pharmabiz33m
WuXi Biologics introduces next-generation platform WuXiHigh2.0 for high-concentration biologics with protein concentration reaching 230 mg/mL
WuXi Biologics introduces next-generation platform WuXiHigh2.0 for high-concentration biologics with protein concentration reaching 230 mg/mL: Shanghai Tuesday, July 1, 2025, 10:0 ...
Pharmabiz1h
Japanese MHLW grants orphan drug designation to Sanofi’s riliprubart for chronic inflammatory demyelinating polyneuropathy
Japanese MHLW grants orphan drug designation to Sanofi’s riliprubart for chronic inflammatory demyelinating polyneuropathy: Paris Tuesday, July 1, 2025, 09:00 Hrs [IST] The Mini ...
Pharmabiz2h
Explore new avenues for drug discovery, targeting novel bacterial pathways & mechanisms: Dr Atul Gogia
Explore new avenues for drug discovery, targeting novel bacterial pathways & mechanisms: Dr Atul Gogia: Nandita Vijayasimha, Bengaluru Tuesday, July 1, 2025, 08:00 Hrs [IST] The d ...
Pharmabiz2h
DCC asks SLAs to implement various regulatory decisions of CDSCO with priority for uniformity
DCC asks SLAs to implement various regulatory decisions of CDSCO with priority for uniformity: Gireesh Babu, New Delhi Tuesday, July 1, 2025, 08:00 Hrs [IST] The Drugs Consultativ ...
Pharmabiz2h
STILL A TOOTHLESS TIGER
But, time has now proven that the Revised UCPMP is still a toothless tiger. The DoP has recently reprimanded AbbVie Healthcare India, the Indian arm of global biopharma major AbbVie Inc, for alleged ...
Pharmabiz2h
India’s medical expertise in robotic surgeries draws patients from across the world
India’s medical expertise in robotic surgeries draws patients from across the world: Nandita Vijayasimha, Bengaluru Tuesday, July 1, 2025, 08:00 Hrs [IST] India’s growing expe ...
Pharmabiz19h
Mabwell’s subsidiary T-mab enters into an agreement with Qilu Pharma for Albipagrastim alfa for injection
Mabwell’s subsidiary T-mab enters into an agreement with Qilu Pharma for Albipagrastim alfa for injection: Shanghai Monday, June 30, 2025, 15:00 Hrs [IST] Mabwell, an innovative ...
Pharmabiz18h
Bone Biologics seeks US patent for bone regeneration technology
Bone Biologics seeks US patent for bone regeneration technology: Burlington, Massachusetts Monday, June 30, 2025, 16:00 Hrs [IST] Bone Biologics Corporation (Bone Biologics), a de ...
Pharmabiz21h
US FDA eliminates REMS for autologous chimeric antigen receptor CAR T cell immunotherapies
US FDA eliminates REMS for autologous chimeric antigen receptor CAR T cell immunotherapies: Maryland Monday, June 30, 2025, 13:00 Hrs [IST] The US Food and Drug Administration (FD ...
Pharmabiz20h
BioPorto initiates commercialization of ProNephro AKI for diagnostic use in US
BioPorto initiates commercialization of ProNephro AKI for diagnostic use in US: Copenhagen, Denmark Monday, June 30, 2025, 14:00 Hrs [IST] BioPorto A/S, an in vitro diagnostics co ...
Pharmabiz21h
Biovica International receives European patent for its assay, DiviTum TKa to determine prognosis of cancer
Biovica International receives European patent for its assay, DiviTum TKa to determine prognosis of cancer: Uppsala, Sweden Monday, June 30, 2025, 13:30 Hrs [IST] Biovica Internat ...